Study #2023-0176
A pilot study for pupillary assessment to predict CAR-T related neurotoxicity
MD Anderson Study Status
Enrolling
Treatment Agent
Description
To learn about the relationship between changes in pupil size and reactivity and the start of neurological side effects in patients after receiving CAR-T cell therapy.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Neurotoxicity
Study phase:
Physician name:
Ranjit Nair
Department:
Lymphoma/Myeloma
For general questions about clinical trials:
1-877-632-6789
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.